Does TOCILIZUMAB Cause Facet joint syndrome? 1,467 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,467 reports of Facet joint syndrome have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 1.5% of all adverse event reports for TOCILIZUMAB.
1,467
Reports of Facet joint syndrome with TOCILIZUMAB
1.5%
of all TOCILIZUMAB reports
1,323
Deaths
1,276
Hospitalizations
How Dangerous Is Facet joint syndrome From TOCILIZUMAB?
Of the 1,467 reports, 1,323 (90.2%) resulted in death, 1,276 (87.0%) required hospitalization, and 1,203 (82.0%) were considered life-threatening.
Is Facet joint syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 1,467 reports have been filed with the FAERS database.
What Other Side Effects Does TOCILIZUMAB Cause?
Drug ineffective (32,342)
Rheumatoid arthritis (20,652)
Pain (18,384)
Off label use (18,256)
Arthralgia (15,536)
Joint swelling (14,831)
Fatigue (13,802)
Rash (12,327)
Drug intolerance (11,952)
Contraindicated product administered (11,547)
What Other Drugs Cause Facet joint syndrome?
RITUXIMAB (1,497)
METHOTREXATE (1,483)
LEFLUNOMIDE (1,464)
DICLOFENAC (1,441)
ALENDRONATE (1,425)
SECUKINUMAB (1,420)
ABATACEPT (1,410)
ADALIMUMAB (1,377)
FOLIC ACID (1,346)
CETIRIZINE (1,337)
Which TOCILIZUMAB Alternatives Have Lower Facet joint syndrome Risk?
TOCILIZUMAB vs TOCILIZUMAB-AAZG
TOCILIZUMAB vs TOCOPHEROL
TOCILIZUMAB vs TOFACITINIB
TOCILIZUMAB vs TOFERSEN
TOCILIZUMAB vs TOLNAFTATE